Kumar Budur

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça et al. · The Lancet Neurology · 2021 · 138 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +4

Sleep disorders in substance abusers: how common are they?

Youssef Mahfoud, Farid Talih, David Streem et al. · PubMed · 2009 · 100 citations

Medicine, Psychiatry, Addiction Psychiatry +16

Advancing combination therapy for Alzheimer's disease

Stephen Salloway, Jeff Sevingy, Kumar Budur et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2020 · 57 citations · Full text

Medicine, Neurology, Pharmacology +16

Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial

Atul R. Mahableshwarkar, Joseph R. Calabrese, Thomas A. Macek et al. · Journal of Affective Disorders · 2017 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Does CPAP treatment in mild obstructive sleep apnea affect blood pressure?

Nattapong Jaimchariyatam, Carlos López Rodríguez, Kumar Budur · Sleep Medicine · 2010 · 28 citations

Medicine, Otolaryngology, Anesthesia +12